Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment

NCT02364336 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Peginterferon alfa-2a

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)